HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinjun Ye Selected Research

Thymopoietins (TP 49)

1/2022Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinjun Ye Research Topics

Disease

12Neoplasms (Cancer)
11/2021 - 10/2016
8Esophageal Squamous Cell Carcinoma
06/2022 - 08/2016
5Neoplasm Metastasis (Metastasis)
09/2021 - 06/2018
4Lung Neoplasms (Lung Cancer)
06/2018 - 04/2017
3Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2021
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2016
3Carcinoma (Carcinomatosis)
01/2020 - 02/2018
2Thrombocytopenia (Thrombopenia)
01/2022 - 10/2019
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022 - 10/2019
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2021
2Anemia
01/2022 - 10/2019
2Vomiting
01/2022 - 10/2019
2Fatigue
01/2022 - 10/2019
1Neutropenia
01/2022
1Esophageal Neoplasms (Esophageal Cancer)
01/2022
1Adenocarcinoma of Lung
09/2021
1Carcinogenesis
01/2021
1Dermatitis
10/2019
1Anorexia
10/2019
1Nausea
10/2019
1Radiation Pneumonitis
10/2019
1Leukopenia
10/2019
1Prostatic Neoplasms (Prostate Cancer)
04/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2015
1Epstein-Barr Virus Infections
01/2014
1Nasopharyngeal Carcinoma
01/2014

Drug/Important Bio-Agent (IBA)

6Paclitaxel (Taxol)FDA LinkGeneric
06/2022 - 10/2016
5Cisplatin (Platino)FDA LinkGeneric
06/2022 - 02/2018
4Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 02/2018
3Long Noncoding RNAIBA
01/2022 - 01/2021
2Biological ProductsIBA
01/2022 - 05/2017
2Carboplatin (JM8)FDA LinkGeneric
01/2022 - 10/2018
2MicroRNAs (MicroRNA)IBA
11/2021 - 10/2021
2RNA (Ribonucleic Acid)IBA
10/2021 - 02/2021
2OligopeptidesIBA
01/2018 - 04/2017
1branched-chain-amino-acid transaminaseIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Thymopoietins (TP 49)IBA
01/2022
1Circular RNAIBA
11/2021
1CateninsIBA
09/2021
1Matrix Metalloproteinases (MMPs)IBA
09/2021
1Antineoplastic Agents (Antineoplastics)IBA
09/2021
1curcumolIBA
09/2021
1lipoteichoic acidIBA
02/2021
1Hematoxylin (Haematoxylon)IBA
02/2021
1Vascular Endothelial Growth Factor CIBA
02/2021
1Eosine Yellowish-(YS) (Eosin)IBA
02/2021
1Competitive Endogenous RNAIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Phospholipid Transfer ProteinsIBA
01/2020
1Sp1 Transcription FactorIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1IntegrinsIBA
06/2018
1InterleukinsIBA
06/2018
1Messenger RNA (mRNA)IBA
06/2018
1Interleukin-8 (Interleukin 8)IBA
06/2018
1ChemokinesIBA
06/2018
1MethyltransferasesIBA
05/2017
1DNA (Deoxyribonucleic Acid)IBA
05/2017
1Poly CIBA
08/2016
1Carrier Proteins (Binding Protein)IBA
08/2016
1Troglitazone (Rezulin)FDA Link
01/2015
1nedaplatinIBA
01/2014

Therapy/Procedure

7Therapeutics
01/2022 - 10/2018
6Chemoradiotherapy
06/2022 - 02/2018
2Radiotherapy
10/2018 - 02/2018
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2022
1Drug Therapy (Chemotherapy)
10/2018